Immunosuppression trends for solid organ transplantation have undergone a perceptible shift over the past decade. Discover the latest research on immunosuppression here.

January 24, 2021

A vasculature-centric approach to developing novel treatment options for glioblastoma.

Expert Opinion on Therapeutic Targets
Hans-Georg WirschingMichael Weller
January 23, 2021
Open Access

Subjective Psychophysical Experiences in the Course of Inflammatory Bowel Disease-A Comparative Analysis Based on the Polish Pediatric Crohn's and Colitis Cohort (POCOCO).

International Journal of Environmental Research and Public Health
Aleksandra Glapa-NowakJarosław Walkowiak
January 23, 2021

Lessons of the month: Massive gastrointestinal bleeding in a young woman with idiopathic thrombocytopenic purpura (ITP).

Clinical Medicine : Journal of the Royal College of Physicians of London
Ksheetij KothariHarshad Devarbhavi
January 21, 2021
Open Access

IFN-γ and CD38 in Hyperprogressive Cancer Development.

Stefania AngelicolaArianna Palladini
January 23, 2021
Open Access

Lamotrigine induced DRESS syndrome in a child: a case report and literature review

Chien-Heng LinI-Ching Chou
January 23, 2021

Belatacept Conversion Protocols and Outcomes in Kidney Transplant Recipients.

Transplantation Proceedings
Mona YazdiRoland Lee
January 23, 2021

Management of Hyperhemolysis in β-thalassemia With Multiple Immunosuppressives, Including Complement Blockade.

Journal of Pediatric Hematology/oncology
Richard C ZanettiThomas C Newton
January 23, 2021

Tuberculous arthritis of the ankle joint masquerading as rheumatoid arthritis in a patient with lupus nephritis.

Clinical Medicine : Journal of the Royal College of Physicians of London
Mohd N Bin Ismail, Siti M Ab Rahim
January 23, 2021
Open Access

Impact of Antibiotics Associated with the Development of Toxic Epidermal Necrolysis on Early and Late-Onset Infectious Complications.

Bretislav LipovyPetra Borilova Linhartova
January 22, 2021

[Vaccinations in dermatology].

Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete
M Sticherling
January 22, 2021

[Laryngeal cancer surveillance in heart transplants].

Vestnik otorinolaringologii
L G KozhanovT V Korshunova
January 23, 2021

Targeting the ubiquitination/deubiquitination process to regulate immune checkpoint pathways.

Signal Transduction and Targeted Therapy
Jiaxin LiuYong Song
January 23, 2021

Dermatological signs in liver transplant recipients.

Journal of Cosmetic Dermatology
Gulbahar SaracSezai Yilmaz

Sign up to follow this feed and discover related papers.

Related Feeds

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Exosomes & Tumor Environment

Several studies have reported the role of exosomes as important mediators of angiogenesis, metastasis, and immune modulation. Exosomes also have the potential to be used as biomarkers for clinical predictions. Here is the latest research on exosomes and the tumor microenvironment.

Graft Rejection

Graft rejection occurs when the donor's grafted tissue is rejected by the recipient's immune system, destroying the transplanted tissue. Discover the latest research on graft rejection here.

Graft vs Host Disease

Graft-versus-host disease (GVHD) is a major cause of morbidity and mortality after allogeneic haematopoietic cell transplantation from unrelated donors. Here is the latest research.

Immune Therapies In Cancer

Immunotherapy in cancer is used to help the immune system fight against invading cancer cells. It is used to slow the progression of the disease and prevent metastasis while enhancing the immune response. There are different types, including monoclonal antibodies and checkpoint inhibitors. Here is the latest research on immune therapies in cancer.


Immuno-oncology (or cancer immunotherapy) is the artificial stimulation of the immune system to treat cancer, improving on the immune system's natural ability to fight cancer. It exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules. Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill. Discover the latest research on immuno-oncology here.

Metastatic Malignancy Treatments

Treatment of metastatic cancers depends on the type of cancer and the severity of the disease. The regime often includes medications such as chemotherapy or hormone therapy, but may also include immunotherapy, radiation therapy, surgery or a combination. Discover the latest research on metastatic cancer treatments here.

Tumor Evasion of the Immune System

Tumor evasion of the immune system includes cells that operate their own growth and develop various strategies to escape from immune surveillance. Discover the latest research on tumor evasion of the immune system here.

Tumor Vaccines

Tumor vaccines offer the potential for preventing cancer in high-risk individuals, preventing disease relapse after diagnosis and initial therapy, and shifting the balance of the host-tumor interaction to mitigate the progression of advanced cancers. Discover the latest research on tumor vaccines here.

© 2021 Meta ULC. All rights reserved